Gossamer Bio Stock Revenue
| GOSS Stock | USD 0.82 0.03 3.53% |
Gossamer Bio fundamentals help investors to digest information that contributes to Gossamer Bio's financial success or failures. It also enables traders to predict the movement of Gossamer Stock. The fundamental analysis module provides a way to measure Gossamer Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gossamer Bio stock.
| Last Reported | Projected for Next Year |
Gossamer | Revenue |
Gossamer Bio Company Revenue Analysis
Gossamer Bio's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Gossamer
Projected quarterly revenue analysis of Gossamer Bio provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Gossamer Bio match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Gossamer Bio's stock price.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Gossamer Bio reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Gossamer Bio is currently under evaluation in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 295,610. Gossamer Bio adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.Gossamer Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Gossamer Bio from analyzing Gossamer Bio's financial statements. These drivers represent accounts that assess Gossamer Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Gossamer Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 855.6M | 662.5M | 846.5M | 183.5M | 139.3M | 132.3M | |
| Enterprise Value | 760.0M | 360.2M | 848.3M | 297.3M | 319.6M | 613.3M |
Gossamer Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Gossamer Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Gossamer Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Gossamer Bio's value.| Shares | T. Rowe Price Associates, Inc. | 2024-06-30 | 5.5 M | Alyeska Investment Group, L.p. | 2024-06-30 | 5.5 M | Eversept Partners, Llc | 2024-06-30 | 5.5 M | Hillhouse Capital Advisors, Ltd. | 2024-06-30 | 5 M | Citadel Advisors Llc | 2024-06-30 | 4.1 M | Opaleye Management Inc | 2024-06-30 | 3.9 M | Deutsche Bank Ag | 2024-06-30 | 3.8 M | Junked Platinum Investment Management Ltd | 2024-06-30 | 3.5 M | Ci Private Wealth Llc | 2024-06-30 | 3.4 M | Nea Management Company, Llc | 2024-06-30 | 18.1 M | Artal Group S A | 2024-06-30 | 13.3 M |
Gossamer Fundamentals
| Return On Equity | -0.9 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.68) % | ||||
| Operating Margin | (3.58) % | ||||
| Current Valuation | 61.41 M | ||||
| Shares Outstanding | 226.6 M | ||||
| Shares Owned By Insiders | 2.94 % | ||||
| Shares Owned By Institutions | 81.83 % | ||||
| Number Of Shares Shorted | 6.3 M | ||||
| Price To Earning | (4.61) X | ||||
| Price To Book | 2.41 X | ||||
| Price To Sales | 1.87 X | ||||
| EBITDA | (172.15 M) | ||||
| Net Income | (179.82 M) | ||||
| Cash And Equivalents | 304.38 M | ||||
| Cash Per Share | 3.29 X | ||||
| Total Debt | 212.46 M | ||||
| Debt To Equity | 3.86 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | 0.24 X | ||||
| Cash Flow From Operations | (159.16 M) | ||||
| Short Ratio | 8.17 X | ||||
| Earnings Per Share | (0.18) X | ||||
| Price To Earnings To Growth | (0.63) X | ||||
| Target Price | 6.72 | ||||
| Number Of Employees | 135 | ||||
| Beta | 1.96 | ||||
| Market Capitalization | 184.82 M | ||||
| Total Asset | 311.92 M | ||||
| Retained Earnings | (1.21 B) | ||||
| Working Capital | 254.92 M | ||||
| Current Asset | 441.63 M | ||||
| Current Liabilities | 39.84 M | ||||
| Net Asset | 311.92 M |
About Gossamer Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Gossamer Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Gossamer Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Gossamer Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Gossamer Stock Analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.